Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma.
Mol Cancer. 2021 Jul 27;20(1):97. doi: 10.1186/s12943-021-01393-9.
Mol Cancer. 2021.
PMID: 34315482
Free PMC article.
No abstract available.
Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1.
Deng Q, Natesan R, Cidre-Aranaz F, Arif S, Liu Y, Rasool RU, Wang P, Mitchell-Velasquez E, Das CK, Vinca E, Cramer Z, Grohar PJ, Chou M, Kumar-Sinha C, Weber K, Eisinger-Mathason TSK, Grillet N, Grünewald TGP, Asangani IA.
Deng Q, et al. Among authors: vinca e.
Cell Rep. 2022 Jun 14;39(11):110971. doi: 10.1016/j.celrep.2022.110971.
Cell Rep. 2022.
PMID: 35705030
Free PMC article.
Item in Clipboard
Cite
Cite